abstracts

P030 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis during Maintenance in the Phase 3 True North Study

12/10/2020

P029 Left Orbital Myositis in a patient with Crohn’s disease in remission with vedolizumab

P029 Left Orbital Myositis in a patient with Crohn’s disease in remission with vedolizumab Sandhu Sunny1, Wang Timothy1, Prajapati Devang1, Donet Jean1

12/10/2020

P028 Outcomes of standard and intensified dosing of ustekinumab for chronic pouch disorders

P028 Outcomes of standard and intensified dosing of ustekinumab for chronic pouch disorders Dalal Rahul1, Gupta Sanchit1, Allegretti Jessica1 1 Brigham and Women's Hospital, Boston, ...

12/10/2020

P027 Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD

12/10/2020

P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study

12/10/2020

P024 Medical decision support system in the diagnosis of ulcerative colitis

12/10/2020

P023 Lower Income Levels in Puerto Ricans with IBD: A Sociodemographic Characterization of a Hispanic Cohort

P023 Lower Income Levels in Puerto Ricans with IBD: A Sociodemographic Characterization of a Hispanic Cohort Nieves-Jiménez Humberto1, Peluyera-García Alondra2, Cuevas-Rodríguez Sa...

12/10/2020

P022 Utilization patterns of infliximab originator to infliximab biosimilar in US Veterans

P022 Utilization patterns of infliximab originator to infliximab biosimilar in US Veterans Pinnell Derek1, Johnson Jessica1, Sauer Brian1, Pei Shoabo1, Chen Wei1, Rojas Jorge1, Gawr...

12/10/2020

P021 Characteristics of Patients Treated with Tofacitinib for Ulcerative Colitis in the Real World: Findings from a Large US Claims Database

P021 Characteristics of Patients Treated with Tofacitinib for Ulcerative Colitis in the Real World: Findings from a Large US Claims Database Chiorean Michael1, Sharma Puza2, Chastek ...

12/10/2020

P020 Incidence of Suboptimal Response to First-Line Anti-TNF Therapy in Patients with IBD in Argentina: Results from the EXPLORE Study

12/10/2020

abstracts

Follow Us on Twitter!

Specialties

Events

Year Round Education

HMP Global Products